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SUPPLEMENTARY MATERIALS fMRI analysis of posttreatment data
Although unfortunately owing to the number of dropouts and ensuing unbalanced design we were unable to perform a mixed effect analysis of variance to test for between-session and between-group effects, we still checked for a relationship between change in brain activity and symptomatic improvement. Although this was not strictly speaking a mediation analysis, its purpose was to clarify whether neural activity of putative biomarkers is being modulated by cCBT and which role it plays in the context of clinical recovery. To this end, we initially fitted the best fitting computational model to the post-treatment behavioural data and used the model fits to run 1 st level fMRI analysis on post-treatment data with same design matrix and contrasts as for pre-treatment data. Subsequent to this, we used the two statistically significant clusters from the pre-treatment 2 nd level unpaired t-test as masks to retrieve the cluster-wise average beta weights from the spatially normalised posttreatment contrast images encoding the weighted RPE. Finally we estimated the cluster-wise difference between pre-and post-treatment beta weights for each subject and correlated these with magnitude of symptomatic change using robust 20% bend correlation. 
